UniProt ID | CDN1B_HUMAN | |
---|---|---|
UniProt AC | P46527 | |
Protein Name | Cyclin-dependent kinase inhibitor 1B | |
Gene Name | CDKN1B | |
Organism | Homo sapiens (Human). | |
Sequence Length | 198 | |
Subcellular Localization | Nucleus. Cytoplasm. Endosome. Nuclear and cytoplasmic in quiescent cells. AKT- or RSK-mediated phosphorylation on Thr-198, binds 14-3-3, translocates to the cytoplasm and promotes cell cycle progression. Mitogen-activated UHMK1 phosphorylation on Ser | |
Protein Description | Important regulator of cell cycle progression. Inhibits the kinase activity of CDK2 bound to cyclin A, but has little inhibitory activity on CDK2 bound to SPDYA. [PubMed: 28666995 Involved in G1 arrest. Potent inhibitor of cyclin E- and cyclin A-CDK2 complexes. Forms a complex with cyclin type D-CDK4 complexes and is involved in the assembly, stability, and modulation of CCND1-CDK4 complex activation. Acts either as an inhibitor or an activator of cyclin type D-CDK4 complexes depending on its phosphorylation state and/or stoichometry.] | |
Protein Sequence | MSNVRVSNGSPSLERMDARQAEHPKPSACRNLFGPVDHEELTRDLEKHCRDMEEASQRKWNFDFQNHKPLEGKYEWQEVEKGSLPEFYYRPPRPPKGACKVPAQESQDVSGSRPAAPLIGAPANSEDTHLVDPKTDPSDSQTGLAEQCAGIRKRPATDDSSTQNKRANRTEENVSDGSPNAGSVEQTPKKPGLRRRQT | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | O-linked_Glycosylation | ------MSNVRVSNG ------CCCCCCCCC | 43.99 | 111190599 | |
2 | Phosphorylation | ------MSNVRVSNG ------CCCCCCCCC | 43.99 | 23403867 | |
7 | Phosphorylation | -MSNVRVSNGSPSLE -CCCCCCCCCCCCHH | 25.55 | 30266825 | |
10 | Phosphorylation | NVRVSNGSPSLERMD CCCCCCCCCCHHHHH | 18.63 | 29255136 | |
12 | Phosphorylation | RVSNGSPSLERMDAR CCCCCCCCHHHHHHH | 44.55 | 30266825 | |
15 | Methylation | NGSPSLERMDARQAE CCCCCHHHHHHHHCC | 33.31 | 24151417 | |
25 | Ubiquitination | ARQAEHPKPSACRNL HHHCCCCCCHHHHHH | 54.21 | - | |
68 | Ubiquitination | NFDFQNHKPLEGKYE CCCCCCCCCCCCCCE | 59.87 | - | |
74 | Phosphorylation | HKPLEGKYEWQEVEK CCCCCCCCEEEEEHH | 33.00 | 19204084 | |
81 | Acetylation | YEWQEVEKGSLPEFY CEEEEEHHCCCCCEE | 60.00 | 7959773 | |
81 | Ubiquitination | YEWQEVEKGSLPEFY CEEEEEHHCCCCCEE | 60.00 | - | |
83 | Phosphorylation | WQEVEKGSLPEFYYR EEEEHHCCCCCEECC | 52.39 | 15034923 | |
88 | Phosphorylation | KGSLPEFYYRPPRPP HCCCCCEECCCCCCC | 9.26 | 19204084 | |
89 | Phosphorylation | GSLPEFYYRPPRPPK CCCCCEECCCCCCCC | 23.20 | 18454177 | |
100 | Acetylation | RPPKGACKVPAQESQ CCCCCCCCCCCCCCC | 51.20 | 22547391 | |
106 | Phosphorylation | CKVPAQESQDVSGSR CCCCCCCCCCCCCCC | 21.43 | 26437602 | |
106 | O-linked_Glycosylation | CKVPAQESQDVSGSR CCCCCCCCCCCCCCC | 21.43 | 144407 | |
110 | Phosphorylation | AQESQDVSGSRPAAP CCCCCCCCCCCCCCC | 39.06 | 28348404 | |
110 | O-linked_Glycosylation | AQESQDVSGSRPAAP CCCCCCCCCCCCCCC | 39.06 | 111190603 | |
112 | Phosphorylation | ESQDVSGSRPAAPLI CCCCCCCCCCCCCCC | 27.82 | 28348404 | |
134 | Ubiquitination | DTHLVDPKTDPSDSQ CCCCCCCCCCCCCCC | 62.18 | 10318797 | |
135 | Phosphorylation | THLVDPKTDPSDSQT CCCCCCCCCCCCCCC | 59.54 | 27251275 | |
138 | Phosphorylation | VDPKTDPSDSQTGLA CCCCCCCCCCCCCHH | 53.34 | 27251275 | |
140 | Phosphorylation | PKTDPSDSQTGLAEQ CCCCCCCCCCCHHHH | 33.70 | 23401153 | |
142 | Phosphorylation | TDPSDSQTGLAEQCA CCCCCCCCCHHHHHH | 37.81 | 27251275 | |
153 | Ubiquitination | EQCAGIRKRPATDDS HHHHCCCCCCCCCCC | 61.89 | 10318797 | |
154 | Methylation | QCAGIRKRPATDDSS HHHCCCCCCCCCCCC | 19.08 | 30762713 | |
154 | Dimethylation | QCAGIRKRPATDDSS HHHCCCCCCCCCCCC | 19.08 | - | |
157 | O-linked_Glycosylation | GIRKRPATDDSSTQN CCCCCCCCCCCCHHC | 42.92 | 10137 | |
157 | Phosphorylation | GIRKRPATDDSSTQN CCCCCCCCCCCCHHC | 42.92 | 15280662 | |
165 | Ubiquitination | DDSSTQNKRANRTEE CCCCHHCHHHCCCCC | 42.97 | 22053931 | |
170 | Phosphorylation | QNKRANRTEENVSDG HCHHHCCCCCCCCCC | 47.67 | 23403867 | |
175 | Phosphorylation | NRTEENVSDGSPNAG CCCCCCCCCCCCCCC | 48.08 | 25849741 | |
178 | Phosphorylation | EENVSDGSPNAGSVE CCCCCCCCCCCCCCC | 21.70 | 23401153 | |
183 | Phosphorylation | DGSPNAGSVEQTPKK CCCCCCCCCCCCCCC | 21.77 | 23403867 | |
187 | Phosphorylation | NAGSVEQTPKKPGLR CCCCCCCCCCCCCCC | 24.46 | 10931950 | |
198 | O-linked_Glycosylation | PGLRRRQT------- CCCCCCCC------- | 38.47 | 17177 | |
198 | Phosphorylation | PGLRRRQT------- CCCCCCCC------- | 38.47 | 15280662 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
10 | S | Phosphorylation | Kinase | KIS | Q8TAS1 | PSP |
10 | S | Phosphorylation | Kinase | RPS6KA3 | P18654 | GPS |
10 | S | Phosphorylation | Kinase | RPS6KA1 | Q63531 | GPS |
10 | S | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
10 | S | Phosphorylation | Kinase | CAMK2A | Q9UQM7 | PSP |
10 | S | Phosphorylation | Kinase | HIPK2 | Q9H2X6 | PSP |
10 | S | Phosphorylation | Kinase | CDK6 | Q00534 | PSP |
10 | S | Phosphorylation | Kinase | CDK16 | Q00536 | PSP |
10 | S | Phosphorylation | Kinase | AKT-FAMILY | - | GPS |
10 | S | Phosphorylation | Kinase | PKB_GROUP | - | PhosphoELM |
10 | S | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
74 | Y | Phosphorylation | Kinase | YES1 | P07947 | GPS |
74 | Y | Phosphorylation | Kinase | SRC64 | - | PhosphoELM |
74 | Y | Phosphorylation | Kinase | SRC | P12931 | Uniprot |
83 | S | Phosphorylation | Kinase | CSNK2B | - | GPS |
83 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
88 | Y | Phosphorylation | Kinase | JAK2 | O60674 | Uniprot |
88 | Y | Phosphorylation | Kinase | SRC64 | - | PhosphoELM |
88 | Y | Phosphorylation | Kinase | LYN | P07948 | Uniprot |
88 | Y | Phosphorylation | Kinase | LYN | P25911 | PSP |
88 | Y | Phosphorylation | Kinase | ABL1 | P00519 | GPS |
88 | Y | Phosphorylation | Kinase | ABL | P00520 | PSP |
88 | Y | Phosphorylation | Kinase | SRC | P12931 | Uniprot |
88 | Y | Phosphorylation | Kinase | YES1 | P07947 | GPS |
88 | Y | Phosphorylation | Kinase | ABL-FAMILY | - | GPS |
89 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
89 | Y | Phosphorylation | Kinase | SRC64 | - | PhosphoELM |
89 | Y | Phosphorylation | Kinase | YES1 | P07947 | GPS |
89 | Y | Phosphorylation | Kinase | ABL1 | P00519 | GPS |
140 | S | Phosphorylation | Kinase | ATM | Q13315 | PSP |
140 | S | Phosphorylation | Kinase | PRKDC | P78527 | GPS |
157 | T | Phosphorylation | Kinase | AKT-FAMILY | - | GPS |
157 | T | Phosphorylation | Kinase | PIM1 | P11309 | Uniprot |
157 | T | Phosphorylation | Kinase | SGK1 | O00141 | PSP |
157 | T | Phosphorylation | Kinase | AKT1 | P31749 | Uniprot |
157 | T | Phosphorylation | Kinase | PKB_GROUP | - | PhosphoELM |
157 | T | Phosphorylation | Kinase | CAMK1A | Q14012 | PSP |
178 | S | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
187 | T | Phosphorylation | Kinase | AKT1 | P31749 | Uniprot |
187 | T | Phosphorylation | Kinase | CDK1 | P06493 | Uniprot |
187 | T | Phosphorylation | Kinase | CDK2 | P24941 | Uniprot |
187 | T | Phosphorylation | Kinase | CDK2 | P97377 | PSP |
187 | T | Phosphorylation | Kinase | CDK6 | Q00534 | PSP |
187 | T | Phosphorylation | Kinase | MAPK3 | P27361 | GPS |
187 | T | Phosphorylation | Kinase | ABL | P00519 | PSP |
187 | T | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
198 | T | Phosphorylation | Kinase | RSK_GROUP | - | PhosphoELM |
198 | T | Phosphorylation | Kinase | RPS6KA3 | P18654 | GPS |
198 | T | Phosphorylation | Kinase | RSK-SUBFAMILY | - | GPS |
198 | T | Phosphorylation | Kinase | PRKAA1 | Q13131 | GPS |
198 | T | Phosphorylation | Kinase | AKT1 | P31749 | Uniprot |
198 | T | Phosphorylation | Kinase | CAMK1A | Q14012 | PSP |
198 | T | Phosphorylation | Kinase | RPS6KA1 | Q15418 | Uniprot |
198 | T | Phosphorylation | Kinase | SGK1 | O00141 | PSP |
198 | T | Phosphorylation | Kinase | PIM1 | P11309 | Uniprot |
198 | T | Phosphorylation | Kinase | RPS6KA1 | Q63531 | GPS |
198 | T | Phosphorylation | Kinase | KS6A3 | P51812 | PhosphoELM |
- | K | Ubiquitination | E3 ubiquitin ligase | CDC34 | P49427 | PMID:19123975 |
- | K | Ubiquitination | E3 ubiquitin ligase | UBE3A | Q05086 | PMID:19591933 |
- | K | Ubiquitination | E3 ubiquitin ligase | COP1 | Q8NHY2 | PMID:26254224 |
- | K | Ubiquitination | E3 ubiquitin ligase | SKP2 | Q13309 | PMID:10375532 |
- | K | Ubiquitination | E3 ubiquitin ligase | RCHY1 | Q96PM5 | PMID:18006823 |
- | K | Ubiquitination | E3 ubiquitin ligase | CDC20 | Q12834 | PMID:22199232 |
- | K | Ubiquitination | E3 ubiquitin ligase | TRIM21 | P19474 | PMID:10323868 |
- | K | Ubiquitination | E3 ubiquitin ligase | RNF123 | Q5XPI4 | PMID:15531880 |
- | K | Ubiquitination | E3 ubiquitin ligase | SIAH2 | O43255 | PMID:21734459 |
- | K | Ubiquitination | E3 ubiquitin ligase | SAG | P10523 | PMID:23136067 |
- | K | Ubiquitination | E3 ubiquitin ligase | WWP1 | Q9H0M0 | PMID:21795702 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CDN1B_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
610755 | Multiple endocrine neoplasia 4 (MEN4) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-140, AND MASSSPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10, AND MASSSPECTROMETRY. | |
"Phosphorylation of p27Kip1 at threonine 198 by p90 ribosomal proteinS6 kinases promotes its binding to 14-3-3 and cytoplasmiclocalization."; Fujita N., Sato S., Tsuruo T.; J. Biol. Chem. 278:49254-49260(2003). Cited for: PHOSPHORYLATION AT SER-10 AND THR-198, INTERACTION WITH YWHAE; YWHAH;SFN; YWHAQ; RPS6KA1 AND RPS6KA3, SUBCELLULAR LOCATION, AND MUTAGENESISOF THR-157 AND THR-198. | |
"Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3and cytoplasmic localization."; Fujita N., Sato S., Katayama K., Tsuruo T.; J. Biol. Chem. 277:28706-28713(2002). Cited for: PHOSPHORYLATION AT SER-10; THR-187 AND THR-198, INTERACTION WITH AKT1AND YWHAQ, SUBCELLULAR LOCATION, AND MUTAGENESIS OF SER-10; THR-157;THR-187 AND THR-198. | |
"A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) andregulates cell cycle progression."; Boehm M., Yoshimoto T., Crook M.F., Nallamshetty S., True A.,Nabel G.J., Nabel E.G.; EMBO J. 21:3390-3401(2002). Cited for: INTERACTION WITH UHMK1, PHOSPHORYLATION AT SER-10, SUBCELLULARLOCATION, AND MUTAGENESIS OF SER-10 AND THR-187. | |
"Phosphorylation at serine 10, a major phosphorylation site ofp27(Kip1), increases its protein stability."; Ishida N., Kitagawa M., Hatakeyama S., Nakayama K.; J. Biol. Chem. 275:25146-25154(2000). Cited for: PHOSPHORYLATION AT SER-10, AND FUNCTION. | |
"Structural basis of the Cks1-dependent recognition of p27(Kip1) bythe SCF(Skp2) ubiquitin ligase."; Hao B., Zheng N., Schulman B.A., Wu G., Miller J.J., Pagano M.,Pavletich N.P.; Mol. Cell 20:9-19(2005). Cited for: X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 181-190 IN COMPLEX WITH SKP1;SKP2 AND CKS1B, PHOSPHORYLATION AT THR-187, MUTAGENESIS OF GLU-185 ANDTHR-187, AND UBIQUITINATION. | |
"Pim kinases promote cell cycle progression by phosphorylating anddown-regulating p27Kip1 at the transcriptional and posttranscriptionallevels."; Morishita D., Katayama R., Sekimizu K., Tsuruo T., Fujita N.; Cancer Res. 68:5076-5085(2008). Cited for: INTERACTION WITH PIM1, AND PHOSPHORYLATION AT THR-157 AND THR-198. | |
"Akt-dependent T198 phosphorylation of cyclin-dependent kinaseinhibitor p27kip1 in breast cancer."; Motti M.L., De Marco C., Califano D., Fusco A., Viglietto G.; Cell Cycle 3:1074-1080(2004). Cited for: PHOSPHORYLATION AT THR-198, SUBCELLULAR LOCATION, AND MUTAGENESIS OFSER-10; THR-157; THR-187 AND THR-198. | |
"PKB/Akt mediates cell-cycle progression by phosphorylation ofp27(Kip1) at threonine 157 and modulation of its cellularlocalization."; Shin I., Yakes F.M., Rojo F., Shin N.-Y., Bakin A.V., Baselga J.,Arteaga C.L.; Nat. Med. 8:1145-1152(2002). Cited for: PHOSPHORYLATION AT THR-157, INTERACTION WITH AKT1, SUBCELLULARLOCATION, FUNCTION, AND MUTAGENESIS OF THR-157; SER-161 AND THR-162. | |
"Cytoplasmic relocalization and inhibition of the cyclin-dependentkinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation inbreast cancer."; Viglietto G., Motti M.L., Bruni P., Melillo R.M., D'Alessio A.,Califano D., Vinci F., Chiappetta G., Tsichlis P., Bellacosa A.,Fusco A., Santoro M.; Nat. Med. 8:1136-1144(2002). Cited for: PHOSPHORYLATION AT THR-157, SUBCELLULAR LOCATION, ASSOCIATION WITHBREAST CANCER, AND MUTAGENESIS OF THR-157. | |
"Cdk-inhibitory activity and stability of p27Kip1 are directlyregulated by oncogenic tyrosine kinases."; Grimmler M., Wang Y., Mund T., Cilensek Z., Keidel E.-M.,Waddell M.B., Jaekel H., Kullmann M., Kriwacki R.W., Hengst L.; Cell 128:269-280(2007). Cited for: STRUCTURE BY NMR OF 22-104, PHOSPHORYLATION AT TYR-88, FUNCTION,INDUCTION, INTERACTION WITH LYN, MASS SPECTROMETRY, AND MUTAGENESIS OFTYR-88 AND TYR-89. | |
"Tyrosine phosphorylation modulates binding preference to cyclin-dependent kinases and subcellular localization of p27Kip1 in the acutepromyelocytic leukemia cell line NB4."; Kardinal C., Dangers M., Kardinal A., Koch A., Brandt D.T., Tamura T.,Welte K.; Blood 107:1133-1140(2006). Cited for: PHOSPHORYLATION AT TYR-88 AND TYR-89, DEPHOSPHORYLATION, INTERACTIONWITH GRB2; CDK2 AND CDK4, SUBCELLULAR LOCATION, AND MUTAGENESIS OFTYR-74; TYR-88 AND TYR-89. |